Enhanced immune responses induced by vaccine using Sendai virosomes as carrier

International Journal of Pharmaceutics

Volumn 329, Issue 1-2, 2007, Pages 117-121

  Li, Qiang ^a,b   Gao, Jian Qing ^a   Qiu, Li Yan ^a   Cui, Fu De ^c   Jin, Yi ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Melanoma; Sendai virosomes; Vaccine

Indexed keywords

CANCER ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CHROMIUM; IMMUNOGLOBULIN G; MELANOMA VACCINE; VIROSOME; VIROSOME VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG FORMULATION; DRUG MEGADOSE; DRUG SYNTHESIS; ENCAPSULATION; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LOW DRUG DOSE; MELANOMA; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENDAI VIRUS; TUMOR IMMUNITY;

ANIMALS; CANCER VACCINES; DRUG DELIVERY SYSTEMS; FEMALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; SENDAI VIRUS; VIROSOMES;

EID: 33845574425     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.08.033     Document Type: Article

References (17)

1. Al-Ahdal M.N., Nakamura I., and Flanagan T.D. Cytotoxic T-lymphocyte reactivity with individual Sendai virus glycoproteins. J. Virol. 54 (1985) 53-57
2. Amselem S., Loyter A., Lichtenberg D., and Barenholz Y. The interaction of Sendai virus with negatively charged liposomes: virus-induced lysis of carboxyfluorescein-loaded small unilamellar vesicles. Biochim. Biophys. Acta 820 (1985) 1-10
3. Arkema A., Huckriede A., Schoen P., Wilschut J., and Daemen T. Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes. Vaccine 18 (2000) 1327-1333
4. Daemen T., Bungener L., Huckriede A., and Wilschut J. Virosomes as an antigen delivery system. J. Lipos. Res. 10 (2000) 329-338
5. Haczku A.F., Kay A.B., and Corrigan C.J. Inhibition of re-expression of surface CD4, but not CD8, on activated human T-lymphocytes by the immunosuppressive drugs dexamethasone and cyclosporine A: correlation with inhibition of proliferation. Int. J. Immunopharmacol. 18 (1996) 45-52
6. Hosaka Y. Sendai virion structure and its interaction with cellular membranes. Electron Microsc. Rev. 1 (1988) 17-38
7. Ishida N., and Homma M. Sendai virus. Adv. Virus Res. 23 (1978) 349-383
8. Jondal M., Schirmbeck R., and Reimann J. MHC-restricted CTL responses to exogenous antigens. Immunity 5 (1996) 295-302
9. Kunisawa J., Nakagawa S., and Mayumi T. Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development. Adv. Drug Deliv. Rev. 52 (2001) 177-186
10. Livingston P.O., Albino A.P., Chung T.J., Real F.X., Houghton A.N., Oettgen H.F., and Old L.J. Serological response of melanoma patients to vaccines prepared from VSV lasates of autologous and allogeneic cultured melanoma cells. Cancer 55 (1985) 713-720
11. Markwell M.A., and Paulson J.C. Sendai virus utilizes specific sialyloligosaccharides as host cell receptor determinants. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 5693-5697
12. Qiang L., Yi J., and Fu-De C. Melanoma vaccine based on the vector of membrane fusogenic liposomes. Pharmazie 59 (2004) 263-267
13. Reis e Sousa C., and Germain R.N. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182 (1995) 841-851
14. Rock K.l., Rothstein L., Gamble S., and Fleischacker C. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J. Immunol. 150 (1993) 438-446
15. Schadendorf D., Paschen A., and Sun Y. Autologous, allogeneic tumor cells or genetically engineered cells as cancer vaccine against melanoma. Immunol. Lett. 74 (2000) 67-74
16. Sheikh N.A., Al-Shamisi M., and Morrow W.J. Delivery systems for molecular vaccination. Curr. Opin. Mol. Ther. 2 (2000) 37-54
17. Vainstein A., Hershkovitz M., Israel S., Rabin S., and Loyter A. A new method for reconstitution of highly fusogenic Sendai virus envelopes. Biochim. Biophys. Acta 773 (1984) 181-188